A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

Bristol-Myers Squibb20 enrolled

Overview

The purpose of this clinical research study is to determine if different dosage regimens of Sinemet® CR (Carbidopa/levodopa) are dose proportional

Study Type

OBSERVATIONAL

Enrollment

Sex: ALLMin age: 50 YearsMax age: 75 YearsHealthy volunteers:

Medical Language ↔ Plain English

* Key inclusion and exclusion criteria for healthy volunteers will be used * Males and females aged 50-75

Local Institution

Toronto, Ontario, Canada

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.